Navigation Links
Tumor in Medical News

Delays in UK child brain tumor diagnosis

Significant numbers of children in the UK are suffering from preventable levels of disability, particularly blindness, and premature death because of poor diagnosis of brain tumours. A new study by scientists at The University of Nottingham's Children's Brain Tumour Research Centre, funded by t...

Amgen and Wyeth Statement on FDA Announcement About Tumor Necrosis Factor (TNF) Blockers

THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Aug. 4 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN ) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), issued a statement in response to the Food and Drug Administration (FDA) announcement regarding the results of a safety rev...

'Suicide' Genes Help Slow Ovarian Tumor Growth in Mice

Treatment could be tested in women within 18 to 24 months, expert suggests THURSDAY, July 30 (HealthDay News) -- Treatment with "suicide" genes slowed ovarian tumor growth in mice and may one day offer a way to treat late-stage ovarian cancer in women, U.S. scientists say. Currently...

Nanoparticle-delivered 'Suicide' Genes Slowed Ovarian Tumor Growth

Potential late-stage ovarian cancer therapy; currently none available; Diphtheria-encoding genes delivered to tumor site by nanoparticles; Laboratory research; possible human trials about 18 months away Philadelphia (Vocus) July 29, 2009 -- Nanoparticle delivery of diph...

Grant for brain tumor and deafness research

Researchers at the Peninsula Medical School have received a grant of over 39,000 from the charity Deafness Research UK, to investigate the role of brain tumours causing deafness in children and adults and the development of therapies using in vitro models. These tumours and a variety of other ...

Study provides documentation that tumor 'stem-like cells' exist in benign tumors

LOS ANGELES (July 22, 2009) Cancer stem-like cells have been implicated in the genesis of a variety of malignant cancers. Research scientists at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute have isolated stem-like cells in benign (pituitary) tumors and used these "mother" c...

New strategy in tumor treatment

A new strategy proposed by researchers at Dartmouth Medical School and Amtek, Hanover, NH may treat tumors that do not respond to conventional treatment. The study, which was published on May 29th in the open access, peer reviewed journal PLoS ONE , uses a combination of two agents to selectively...

Gene Connections Key to Brain Tumor Growth

Discovery could help change disease from fatal to chronic, researcher says TUESDAY, July 14 (HealthDay News) -- Researchers have identified a network of mutated genes and gene processes that, together, contribute to the development of glioblastomas, the deadliest type of brain tumor. ...

Drug Shows Promise in Nervous-System Tumor Treatment

In small study, some patients had their hearing restored WEDNESDAY, July 8 (HealthDay News) -- U.S. researchers report the first successful drug treatment of tumors in patients with neurofibromatosis type 2 (NF2). In people with NF2, benign tumors develop throughout the nervous sy...

Carbohydrate acts as tumor suppressor

LA JOLLA, Calif., July 6, 2009 Scientists at Burnham Institute for Medical Research (Burnham) have discovered that specialized complex sugar molecules (glycans) that anchor cells into place act as tumor suppressors in breast and prostate cancers. These glycans play a critical role in cell adhesi...

6th Annual Neurosurgery Charity Softball Tournament Hits It Out of the Park For Pediatric Brain Tumor Research Fund

WESTCHESTER, Ill., July 1 /PRNewswire/ -- The Pediatric Brain Tumor Research Fund of Columbia University Medical Center (the Fund) and BrainLAB teamed up again this year for the 6th Annual Charity Softball Tournament and all-star after-party at ESPNZone in New York City. The June 6 event raised ...

Study identifies biomarker that safely monitors tumor response to new brain cancer treatment

LOS ANGELES (STRICTLY EMBARGOED UNTIL 12:01 A.M. EDT on JULY 1, 2009) A specific biomarker, a protein released by dying tumor cells, has been identified as an effective tool in an animal model to gauge the response to a novel gene therapy treatment for glioblastoma mulitforme. The finding, repor...

Determining Who Will Respond to Brain Tumor Therapy

Blood biomarker, combined with MRI scan, helps predict outcome, study finds,, TUESDAY, June 23 (HealthDay News) -- A new biomarker that may help predict whether someone with a brain tumor will respond to a given treatment has been identified by U.S. researchers. Looking to see who w...

Targeting tumor behavior may lead to new liver cancer drugs

COLUMBUS, Ohio Ohio State University cancer researchers have used computational and genomic methods to identify possible anti-cancer agents that may block a particular kind of tumor behavior. The agents target multiple genes associated with that behavior at one time. The researchers wanted to f...

Promising biomarker and candidate tumor suppressor gene identified for colorectal cancer

Researchers have identified a new candidate tumor suppressor gene in colorectal cancer and examined its use as a potential biomarker in stool samples, according to a new study published online June 17 in the Journal of the National Cancer Institute . In the study, Manon van Engeland, Ph.D., of...

Potential for noninvasive brain tumor treatment

DURHAM, N.C. -- Duke University engineers have taken a first step toward a minimally invasive treatment of brain tumors by combining chemotherapy with heat administered from the end of a catheter. The proof-of-concept study demonstrated that it should be technically possible to treat brain tum...

'Outsmarting Brain Tumors': Cedars-Sinai Researchers, Neurosurgeons and Other Experts Present Free Conference for Adult Brain Tumor Patients and Caregivers

LOS ANGELES, June 1 /PRNewswire/ -- Neurosurgeons, brain tumor researchers and other professionals affiliated with Cedars-Sinai Medical Center's Department of Neurosurgery will present a one-day conference, "Outsmarting Brain Tumors," on Saturday, June 13, from 7:45 a.m. to 4:30 p.m. The free ...

Carbohydrate restriction may slow prostate tumor growth

DURHAM, N.C. -- Restricting carbohydrates, regardless of weight loss, appears to slow the growth of prostate tumors, according to an animal study being published this week by researchers in the Duke Prostate Center. "Previous work here and elsewhere has shown that a diet light in carbohydrates ...

Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Sarcoma and Osteosarcoma: Phase I/II and Phase II Studies, ASCO 2009

SAN MARINO, Calif., May 18 /PRNewswire/ -- Epeius Biotechnologies ( www.epeiusbiotech.com ) today announced the results of two related studies using Rexin-G, a tumor-targeted anti-cancer agent designed to seek-out and destroy metastatic cancers that have spread throughout the body. While Rex...

Bonnie Hunt, Melina Kanakaredes and Dr. Ruth Westheimer Lend Their Support to Children's Brain Tumor Foundation Benefit

Former Oncology Nurse helps honor heroes of fight against pediatric neuro-oncology NEW YORK, May 13 /PRNewswire-USNewswire/ -- Bonnie Hunt served as Mistress of Ceremonies at this year's 7th Annual Dream & Promise Awards Gala, held on Wednesday, May 13, 2009, at the Marriott Marquis in Ti...

Walk Raises Almost $200,000 to Heighten Brain Tumor Awareness

WILMINGTON, Del., May 5 /PRNewswire/ -- The "Get Your Head in the Game(R)" Awareness Walk held here on May 2 raised $198,417 for The Kelly Heinz-Grundner Brain Tumor Foundation (KHG), the only organization in the US primarily focused on education and awareness of brain tumors. (Pho...

Where tumor cells boldly go: Weill Cornell cancer biologists shed light on the metastatic niche

NEW YORK (May 1, 2009) -- Traditionally, cancer biologists have embraced a simple and direct model of the disease process: The tumor -- the "seed" -- was seen as bearing total responsibility for the spread of cancer to distant tissues -- the "soil" in which the seed embedded itself, grew, and repr...

Two UCLA Neurosurgeons to Be Showcased in Documentary for the First Official National Brain Tumor Awareness Month

Two UCLA neurosurgeons will be featured in a documentary for the Nation's first Brain Tumor Awareness Month. These two neurosurgeons will put their skills to the test as they perform surgery to save a father and his thirteen year old stepson. TAMPA, Fla., April 30 /PRNewswire/ -- Two of UC...

Drug therapy reduces neuroblastoma tumor growth in pre-clinical investigation

SAN DIEGO - Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have discovered a new drug combination that significantly hinders tumor growth in neuroblastoma, a childhood cancer. The study was presented today at the 22nd annual meeting of the A...

Progen Technology Switches on Cancer Fighting Genes and Inhibits Tumor Growth

BRISBANE, Australia, April 20 /PRNewswire-FirstCall/ --Progen Pharmaceuticals Limited (ASX: PGL; Nasdaq: PGLA ) has released data that shows its epigenetic technology successfully inhibits tumor growth. The results of the pre-clinical experiments, presented by Progen's collaborators at the ...

USC researchers develop new drug to target tumor cells and blood vessels

Researchers at the University of Southern California have identified a new drug compound that appears to target tumor cells and surrounding blood vessels without the negative side effects typically associated with Cox-2 inhibitors. The compound 2.5-dimethyl-celecoxib (DMC) appears to have a s...

Reversing effects of altered enzyme may fight brain tumor growth

An international team of scientists from the Moores Cancer Center at the University of California, San Diego, the University of North Carolina and several institutions in China have explained how a gene alteration can lead to the development of a type of brain cancer, and they have identified a co...

Milestone tumor virus publication by Elsevier journal Virology

Amsterdam, 9 April 2009 A recent special edition of the Elsevier journal Virology ( www.elsevier.com/locate/viro ), reviews the past, present, and future of the exciting field of small DNA tumor viruses. Many of the leaders in the field, including Dr Harald Zur Hausen, who was honored with the ...

Mayo researchers discover mechanism of cell type-specific signaling in tumor development

ROCHESTER, Minn. Mayo Clinic researchers have discovered the mechanisms behind two key checkpoints in cell growth and development factors that may ultimately allow investigators to benchmark progression of tumor cells or stop them from further development. The findings appear in the current onli...

Avastin effective at delaying brain tumor progression in recurrent disease

(SEATTLE) The use of Avastin alone to treat a subgroup of recurrent Grade 3 brain tumors showed it was safe and effective at delaying tumor progression, according to a retrospective study of 22 patients conducted by a researcher at the Seattle Cancer Care Alliance. The patients all had a recurr...

Gene helps protect tumor suppressor in breast cancer

HOUSTON - Scientists at The University of Texas M. D. Anderson Cancer Center have discovered a gene that protects PTEN, a major tumor-suppressor that is reduced but rarely mutated in about half of all breast cancers. The gene Rak helps protect and regulate PTEN, which also is important in sever...

Blood protein may hold key to stopping tumor growth in cancer patients

WINSTON-SALEM, N.C. A recent discovery by researchers at Wake Forest University School of Medicine could clear the way for a new drug that inhibits tumor growth in cancer patients and could potentially help in the healing of wounds. The discovery stems from a study, recently published in the ...

Angiogenesis inhibitor improves brain tumor survival by reducing edema

The beneficial effects of anti-angiogenesis drugs in the treatment of the deadly brain tumors called glioblastomas appear to result primarily from reduction of edema the swelling of brain tissue and not from any direct anti-tumor effect, according to a study from Massachusetts General Hospital (...

Study finds biological clue in brain tumor development

Scientists at The University of Nottingham have uncovered a vital new biological clue that could lead to more effective treatments for a children's brain tumour that currently kills more than 60 per cent of young sufferers. Clinician scientists at the University's Children's Brain Tumour Resear...

MicroRNA undermines tumor suppression

FINDINGS: Scientists at the Whitehead Institute for Biomedical Research and the National University of Singapore have discovered the first microRNA (miRNA) capable of directly tamping down the activity of the well known tumor-suppressor gene, p53, While p53 functions to prevent tumor formation, th...

Iron induces death in tumor cells

Rapid growth of cancer cells and their frequent divisions have their price: Cancer cells need considerably more energy than healthy cells. Their metabolism runs at full speed and requires large amounts of micronutrients, particularly iron. However, high levels of iron in the cell lead to the produ...

SOX9 renders melanomas sensitive to retinoic acid and stops tumor growth

Melanomas are often resistant to standard cancer therapies such as radiotherapy, chemotherapy, and retinoic acid (RA). Given the lack of available treatments for melanoma, the prognosis for patients is often poor. However, Vincent Hearing and colleagues at the National Cancer Institute at the Nati...

Combo Treatment for Aggressive Brain Tumor May Lengthen Life

Study finds longer-term survival benefit with chemo and radiation MONDAY, March 9 (HealthDay News) -- Treatment with a combination of the chemotherapy drug temozolomide and radiotherapy increases survival for glioblastoma brain tumor patients better than radiotherapy alone, and the im...

Brain Tumor Drug May Help Spur Cancer's Return

But insights into how that happens may lead to ways around it, researchers say,,,, THURSDAY, March 5 (HealthDay News) -- Temozolomide, a standard treatment for brain cancer, may boost the aggressiveness of surviving cancer cells, making tumor recurrence more likely, a new study suggest...

Brain tumor treatment may increase number of cancer stem-like cells

A new study suggests that the standard treatment for a common brain tumor increases the aggressiveness of surviving cancer cells, possibly leaving patients more vulnerable to tumor recurrence. The research, published by Cell Press in the March 6th issue of the journal Cell Stem Cell , provides va...
Other Tags
(Date:4/22/2014)... have presented Beaumont Health System with prestigious, competitive ... both athletic and nonathletic injuries. , The ... $40,000 grant to fund stem cell-based research that ... a ruptured knee anterior cruciate ligament, or ACL. ... anterior cruciate ligament injury is the over-stretching or ...
(Date:4/22/2014)... the University of Kentucky has discovered new methods to ... , The research, led by Peixuan Guo, professor and ... UK College of Pharmacy and Markey Cancer Center, is ... Anionic Polymer Material To Build Robust Structures with Defined ... Daniel L. Jasinski. , The article, which will appear ...
(Date:4/22/2014)... thousands of breeding bird surveys sent in by citizen ... 35 years, wildlife researchers report that most of the ... toward higher elevation in response to climate change, but ... most previous studies of potential climate change impacts on ... other have likely underestimated the effects of environmental warming, ...
Breaking Biology News(10 mins):Beaumont awarded grants to study sports-related injury treatment, improve recovery 2RNA shows potential as boiling-resistant anionic polymer material for nanoarchitectures 2Wildlife response to climate change is likely underestimated, experts warn 2
(Date:4/22/2014)... 15 percent of all lung cancers are small ... often develop resistance to chemotherapy. However, researchers at ... new insights into the mechanisms leading to this ... , Chemotherapies work primarily by mediating B-cell lymphoma ... regulating cell death. Depending on their function, this ...
(Date:4/22/2014)... The Association for Molecular Pathology (AMP) released a ... Diagnostics on recommendations for a molecular diagnostics ... of education. The report was prepared by the ... the AMP Training and Education Committee. "Our goal ... future medical laboratory scientists appropriately in order to ...
(Date:4/22/2014)... rabbits, Johns Hopkins scientists have found a way to ... the development of atherosclerosis, the main cause of heart ... among humans. The condition develops when fat builds inside ... and hardened, greatly reducing their ability to feed oxygen-rich ... In a series of experiments, described April 7 in ...
(Date:4/22/2014)... German . , ... their mode of action is complex: In low concentrations ... while at high concentrations they can cause "oxidative stress", ... redox signaling unfolds in single cells and organelles in ... jointly by the teams of LMU Professor Martin Kerschensteiner ...
(Date:4/22/2014)... in massive health care spending, a new RAND study ... to incentivize pharmaceutical companies and device makers to develop ... existing medical technologies and their use, a new study ... and medical devices get created in the first place. ... with as little loss of health as possible and ...
Breaking Medicine News(10 mins):Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:AMP publishes curriculum recommendations for medical laboratory scientists 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 4Health News:Neuroimaging: Live from inside the cell 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3
Other Contents